Fourth quarter Sales from Elev8 Hemp and Zoe CBD Up Over 30%
Feb 09, 2018 13:31 pm UTC| Business
ORLANDO, Fla., Feb. 09, 2018 -- Via OTC PR Wire -- Elev8 Brands, Inc. (OTC Pink:VATE), a holding company focused on the commercial development of hemp and CBD-based products including hemp coffee, tea, E-juices, CBD...
Hi-Crush Partners LP to Participate in Credit Suisse Annual Energy Summit
Feb 09, 2018 13:31 pm UTC| Business
HOUSTON, Feb. 09, 2018 -- Hi-Crush Partners LP (NYSE:HCLP), or Hi-Crush, today announced that Robert E. Rasmus, Chief Executive Officer, and Laura C. Fulton, Chief Financial Officer, will present and meet with investors...
HMS Holdings Corp. To Report Fourth Quarter and Full Year 2017 Financial and Operating Results
Feb 09, 2018 13:31 pm UTC| Business
IRVING, Texas, Feb. 09, 2018 -- HMS Holdings Corp. (NASDAQ:HMSY) today announced it will report fourth quarter and full year 2017 financial and operating results at 7:30 am CT / 8:30 am ET on Friday, February 23, 2018. ...
NetworkNewsWire Announces Publication on Cryptos Taking Front and Center Amid Market Evolution
Feb 09, 2018 13:31 pm UTC| Business
NEW YORK, Feb. 09, 2018 -- – via NetworkWire – NetworkNewsWire ("NNW"), a multifaceted financial news and publishing company, today announces the publication of an editorial featuring SinglePoint, Inc. (OTC:SING), a...
Feb 09, 2018 13:31 pm UTC| Business
NEW YORK, Feb. 09, 2018 -- via NetworkWire – NetworkNewsWire ("NNW"), a multifaceted financial news and publishing company, today announces the publication of an editorial featuring ChineseInvestors.com, Inc....
Globus Medical Schedules Fourth Quarter and Full Year 2017 Earnings Release and Conference Call
Feb 09, 2018 13:30 pm UTC| Business
AUDUBON, Pa., Feb. 09, 2018 -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, will announce its financial results for the fourth quarter and full year ended December 31, 2017 after the...
Aquinox Provides Enrollment Update for LEADERSHIP 301 Clinical Trial of Rosiptor
Feb 09, 2018 13:30 pm UTC| Business
--Enrollment target reached; topline data on track for Q3 2018 announcement-- NEW YORK, Feb. 09, 2018 -- Aquinox Pharmaceuticals, Inc. ("Aquinox") (NASDAQ:AQXP), a clinical-stage pharmaceutical company discovering and...